- ASX anticipates capital expenditure of A$135 million for FY24, within their forecast range of A$110 million to A$140 million.
- Expenses are expected to increase by 15%, previously estimated to rise between 12% and 15%.
- Projected FY25 total expense growth rate is between 6% and 9%.
- FY25 technology capital expenditure is forecasted between A$160 million and A$180 million, with similar levels expected through FY27 before decreasing.
- ASX plans to maintain its dividend payout ratio between 80% and 90% of underlying net profit after tax through the medium term.
- The FY25 expense growth is primarily driven by continued investment in technology.
- ASX will keep focusing on expense management initiatives in FY25.
- Current analyst ratings: 1 buy, 7 holds, and 4 sells.
“`
A look at ASX Ltd Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
“`html
Analysing ASX Ltd utilizing Smartkarma Smart Scores reveals a promising long-term outlook for the company. With a solid Resilience score of 4, ASX Ltd demonstrates a robust ability to weather market fluctuations and economic challenges. This resilience indicates the company’s capacity to adapt and thrive in various market conditions, ensuring stability in its operations.
Furthermore, ASX Ltd‘s Momentum score of 4 suggests strong upward momentum in its performance, indicating positive trends and potential for continued growth. This, coupled with respectable scores in Dividend and Growth categories, positions ASX Ltd well for sustained success in the future. While there is room for improvement in the Value category, the overall outlook for ASX Ltd appears optimistic based on its favorable Smart Scores.
“`
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
